Mycobacterial and Fungal Infections in Dialysis Pa

Information about Mycobacterial and Fungal Infections in Dialysis Pa

Published on May 7, 2008

Author: Marigold

Source: authorstream.com

Content

Unusual Peritonitis: Diagnosis and Management: Mycobacterial and Fungal :  Unusual Peritonitis: Diagnosis and Management: Mycobacterial and Fungal Bill Salzer University of Missouri-Columbia 2/20/07 [email protected] Mycobacteria:  Mycobacteria Tuberculosis Human pathogen- person to person via aerosol 1/3 of the world’s population is infected US- 15,000 cases/year, >50% foreign born Controlled by cell mediated immunity Non-tuberculous mycobacteria Acquired from the environment- water, soil, dust Less virulent than TB Slide7:  TB Course N Engl J Med 345:192 TB in ESRD:  TB in ESRD Most active cases are reactivation disease Risk of reactivation is 5-20 fold higher than non ESRD Anergy- false negative PPD common Risk is dependent on PPD+ rate- geographical Most cases occur in 1st year on dialysis Extra-pulmonary disease in >50% Atypical presentations TB in ESRD- Clinical Features:  TB in ESRD- Clinical Features Atypical presentations common, some asymptomatic Malaise-70%, fever-70%, weight loss 50% Cough and hemoptysis- 22% Abnormal CXR- 50%, atypical patterns Extra-pulmonary- lymph nodes, pleural, miliary Peritonitis- 20%, pain, ascites, hepatomegaly Diagnosis is often delayed TB Peritonitis in PD Patients:  TB Peritonitis in PD Patients Reactivation disease, sometimes miliary Presents like bacterial- fever, pain, cloudy fluid Refractory to antibiotics, routine cultures usually – Concomitant bacterial peritonitis in 28% Peritoneal WBCs predominantly PMNs in ¾ Fluid AFB smears + in <20%, cultures only 50% + Delays in diagnosis common- mean 6weeks Delays increase mortality, catheter loss Mycobacterial Diagnosis:  Mycobacterial Diagnosis Direct smear Auramine, rhodamine- fluorescent, screen specimens Ziehl-Neelsen, Kinyoun- Acid-fast, carbol-fuchsin Cultures BACTEC- quick 1-2 weeks Solid media- Löwenstein-Jensen, Middlebrook - slow TB or not TB that is the? Biochemicals- slow DNA probes, GLC, NAP- quick MTB PCR?- smear +, 95-98% sensitive Drug susceptibility testing- old and new TB Peritonitis in PD- Diagnosis:  TB Peritonitis in PD- Diagnosis AFB fluid smears positive in < 20% AFB fluid cultures positive in only 50% PPDs positive in 50%, specificity in endemic areas? Eli-spot test? Quicker and better Promising results with direct PCR of fluid Peritoneal biopsy and cultures- nearly 100% yield Caseating granulomas on biopsy Slide13:  Elad, Y. et. al. N Engl J Med 1998;339:1382-1387 Epithelioid Granulomata with Multinucleated Giant Cells against a Background of Necrotic Lymphoid Tissue (Hematoxylin and Eosin, x400) TB Treatment in ESRD:  TB Treatment in ESRD At least 3 or 4 drugs initially INH 300mg/d + rifampin 600mg/d + pyrazinamide 25-35mg/kg TIW + quinolone +pyridoxine 100mg/d Quinolone- moxifloxacin 400mg po/d? Modify based on drug susceptibilities ?drug resistant strains Duration 6 months Catheter removal- controversial, not always required Dose modification for ethambutol, streptomycin, quinolones, PZA as above Prevention of TB in ESRD Patients:  Prevention of TB in ESRD Patients Identify and treat latent TB infections PPD skin tests for all with ESRD, early “A decision to test is a decision to treat” Induration 10mm= +, CXR to R/O active pulmonary Preventive therapy for all positives INH 300mg/d + pyridoxine 100mg for 9 months Rifampin 600 mg/d for 4 months Rifampin 300 mg/d + PZA 25-35 mg/kg TIW for 2 months Watch for hepatitis with RF+PZA regimen Quantiferon-TB Gold:  Quantiferon-TB Gold Test for latent TB infection Blood test- measures in vitro IFN-gamma production Uses ESAT-6 and CFP-10 as stimulants More specific than PPD (96-98%) in BCG pt ?more sensitive than PPD Problems Cost Availability How sensitive? Nontuberculous Mycobacteria:  Nontuberculous Mycobacteria > 100 species, 60 pathogens Runyon classification- colony, growth rate, pigment Now growth rate, molecular Environmental sources No human to human transmission Less virulent than MTB Diseases, host immune status Geography NTM- Sources:  NTM- Sources Water including, tap, nosocomial Soil Animals Aerosolized Ingested Direct inoculation- trauma, surgical MAC everywhere, Malmoense, genavense- Europe M. ulcerans- tropical swamps Non-TB Mycobacterial PD Infections:  Non-TB Mycobacterial PD Infections Environmental- soil, water, dust, direct contamination Predominantly rapid growers- M fortuitum, chelonei Contaminated machines, water, outbreaks Peritonitis, exit or tunnel infections, abscess Like bacterial- fever, pain, cloudy fluid Peritoneal WBCs usually predominantly PMNS Gram stain may show gram + rods- diphtheroids Culture negative, refractory to antibiotics NTM- Microbiology:  NTM- Microbiology Digestion, decontamination- careful AFB smear- Auramine, Kinyoun Media- Middlebrook, BACTEC, MGIT Rapid < 7d, slow > 10d, medium 7-10 Skin source- incubate at 28-30 C- marinum et al M. genavense, malmoense, ulcerans- 10-12 weeks M. Haemophilum- needs iron, cool and slow Species- HPLC, gene probes, biochemicals Rapid Growing NTMs:  Rapid Growing NTMs M. fortuitum, abscessus, chelonei Grow in < 7days Fortuitum and abscessus grow on MacConkey Chelonei like cooler temp Sources- soil, natural and tap water Nosocomial- wounds- sternal, mammoplasty, IM sites Virulence- fortuitum>abscessus>chelonei NTBM Peritonitis- DX and RX:  NTBM Peritonitis- DX and RX Gram stain may show gram + rods, AFB + Routine cultures- 2-10 days “diphtheroids” AFB cultures +- species identification takes time Peritoneal biopsy- non-caseating granulomas, culture Treatment Catheter removal usually necessary Inherently resistant to most TB drugs Clarithromycin, quinolones, doxycycline, sulfa, amikacin, tobramycin, imipenem, cefoxitin 1-2 drugs, 4-24 months duration Slide24:  Infectious Disease Clinics of North America 15: number 3 p756, 2001 Fungal Peritonitis in PD Patients:  Fungal Peritonitis in PD Patients Filamentous fungi (molds) Environmental, catheter contamination, bad dx and rx Candida- yeast Endogenous flora- GI, GU, skin sources, nosocomial Risks Recent antibiotics- 65%, bacterial peritonitis- 48% Emergency PD Recent hospitalization HIV infection- 7 X risk of non-HIV Extra-peritoneal infection, abdominal surgery Candida Peritonitis in PD:  Candida Peritonitis in PD Via catheter, tunnel, or ? Ascending in women Like bacterial- fever, pain, cloudy fluid, > 75% PMNs Refractory to antibiotics Fluid gram stains reveal yeast in 50% Fluid cultures + 99% on routine media Fungal Peritonitis Treatment:  Fungal Peritonitis Treatment ISPD Guideline 2005 Remove catheter Fluconazole 200mg/d +Flucytosine 2gm X1d,then 1gm/d Duration 2-4 weeks Check antifungal susceptibilities, species Fluconazole resistant? Oral azoles- itraconazole, voriconazole, posaconazole Amphotericin B Echinocandins- caspofungin, micafungin, anidulofungin Azole Resistance in Candida:  Azole Resistance in Candida Fluconazole C albicans is the most susceptible species Tropicalis>parapsilosis>> glabrata, krusei Non-albicans species increasing in nosocomial Fluconazole failure related to species Check species, drug susceptibilities if available Newer azoles are more active on these strains Candida albicans:  Candida albicans http://www.doctorfungus.org Candidemia- Species UMC :  Candidemia- Species UMC 2/02-2/03 3/03-1/04 Totals Species cases % cases% C. Parapsilosis 7 33% 1 11 21% C. Albicans 5 24% 6 32 28% C. Tropicalis 4 19% 4 21 21% C. Glabrata 4 19% 7 37 28% C. Famata 1 5% 0 2% Slide31:  Candida in vitro azoles CID 36: Fluconazole (“Diflucan”):  Fluconazole (“Diflucan”) Generic- cheap now Well absorbed po, hydrophilic (CSF, urine,perotoneum) Renal excreted- dose adjustment for renal function Active candida (?glabrata,krusei) crypto, cocci Side effects GI, headache, rash, alopecia, hepatitis Drug interactions Inhibits CYP 3A4, 2C19 Flucytosine:  Flucytosine 5-fluorocytosine- fluorinated pyrimidine (1972) Fungal cytosine permease, cytosine deaminase- 5-FU Inhibits RNA synthesis, thymidylate synthetase PO 25-37.5 mg/kg q6h; renal excretion Monitor serum levels- 30-60 min post dose- 50-100ug/ml Renal insufficiency- 2grams day 1, then 1 gram/day CSF levels 74% of serum- hydrophilic Toxicity- hematological, GI- with high levels Itraconazole (“Sporanox”):  Itraconazole (“Sporanox”) PO caps, liquid (cyclodextrin); IV Absorption capsules pH dependent, liquid not Lipophilic, hepatic metabolism Activity-candida, aspergillus, histo, blasto, sporo, cocci, dermatophytes Side effects GI, liver, rash, hypokalemia, edema, BP Drug interactions Inhibits CYP3A4 Voriconazole (“Vfend”):  Voriconazole (“Vfend”) Triazole antifungal, IV and PO forms Antifungal activity like itra- candida, crypto, histo, blasto, aspergillus, other filamentous Well absorbed orally, food decreases Liver metabolism- CYP- 2C19, 2C9, 3A4 Not much in urine or CSF (like itra) IV- cyclodextrin vehicle, don’t use if GFR<50 Side effects- Visual in 30% Drug interactions- sirolimus, rifamycins, statins etc Voriconazole for Candida Peritonitis:  Voriconazole for Candida Peritonitis Kleinpeter MA.AdvPeritDial 2004;20:58-61 Report of 2 cases Case 1- Exit site infection Candida species resistant to fluconazole Voriconazole po for 28 days- Success, retained cath Case 2 peritonitis Candida parapsilosis Success with cath in place Posaconazole- “Noxafil”:  Posaconazole- “Noxafil” Approved in 2006 PO, liquid suspension, take with food Activity- like voriconazole + some Zygomycetes Good activity on fluconazole resistant candida Metabolized by UDP glucuronidation Inhibits CYP-3A4 No dose adjustment for renal Echinocandins:  Echinocandins Inhibit Beta 1,5-D glucan synthase IV only Activity- candida species, aspergillus species No activity on other yeasts, ? Molds Class side effects Histamine reaction, flushing, prurutis, low BP Phlebitis Fever Mild LFT elevation Echinocandins- Pharmacology:  Echinocandins- Pharmacology Caspofungin- “Cancidas” IV 70mg day 1, subsequently 50 mg/day Hepatic metabolism, not CYP, reduce with ESLD Drug interactions- cyclosporine, tacrolimus, rifampin Micafungin- “Mycamine” IV 50-150mg/day, probably 100 Hepatic metabolism, non CYP, Anidulofungin- “Eraxis” IV day 1 200mg, subsequently 100mg/d, < 1.1mg/min Metabolized in serum- no dose adjustment Antifungals for PD peritonitis:  Antifungals for PD peritonitis Remove catheter Fluconazole empirically, ? + flucytosine Fluconazole resistant C. glabrata, krusei- assume resistan Drug susceptibility testing Itra-, vori- or posaconazole PO Amphotericin B or echinocandin IV Filamentous fungus Remove catheter Voriconazole, posaconazole, ampho B

Related presentations


Other presentations created by Marigold

High Touch Concept
08. 05. 2008
0 views

High Touch Concept

ismptt
02. 05. 2008
0 views

ismptt

perfeval 20021108
02. 05. 2008
0 views

perfeval 20021108

hegland track 2
02. 05. 2008
0 views

hegland track 2

Stories
02. 05. 2008
0 views

Stories

lecture01 intro
02. 05. 2008
0 views

lecture01 intro

presentation
30. 04. 2008
0 views

presentation

Oracle Order Management 2006
28. 04. 2008
0 views

Oracle Order Management 2006

WHCE March 06
22. 04. 2008
0 views

WHCE March 06

4th grade Plant Adaptations
03. 01. 2008
0 views

4th grade Plant Adaptations

psychosocial intervention
28. 09. 2007
0 views

psychosocial intervention

8 Geomorphic Regions
02. 10. 2007
0 views

8 Geomorphic Regions

SmokeScreen
10. 10. 2007
0 views

SmokeScreen

Roger Stough and Cheng
16. 10. 2007
0 views

Roger Stough and Cheng

Elfaro
22. 10. 2007
0 views

Elfaro

STOCONT2006SLIDESCOR SO
24. 10. 2007
0 views

STOCONT2006SLIDESCOR SO

Com oraleITB
24. 10. 2007
0 views

Com oraleITB

PC chap1 5
16. 10. 2007
0 views

PC chap1 5

hadron99nakada
17. 10. 2007
0 views

hadron99nakada

324l1 int
29. 10. 2007
0 views

324l1 int

MIS CI
29. 09. 2007
0 views

MIS CI

7bL Romantic Music
23. 11. 2007
0 views

7bL Romantic Music

Melihovs Phillips
23. 11. 2007
0 views

Melihovs Phillips

esf coruna
29. 12. 2007
0 views

esf coruna

The Civil War Presidents
31. 12. 2007
0 views

The Civil War Presidents

uganda 02
04. 01. 2008
0 views

uganda 02

Water Quality for Animals
04. 01. 2008
0 views

Water Quality for Animals

thinking wertheim 14jan05
07. 01. 2008
0 views

thinking wertheim 14jan05

07cury
01. 01. 2008
0 views

07cury

of 10 emiranda MagSc
12. 10. 2007
0 views

of 10 emiranda MagSc

land
04. 10. 2007
0 views

land

Roosevelt and U S Imperialism
25. 10. 2007
0 views

Roosevelt and U S Imperialism

IP FSM fin EN
01. 10. 2007
0 views

IP FSM fin EN

naaman
02. 11. 2007
0 views

naaman

mypyramid calorie salary
04. 03. 2008
0 views

mypyramid calorie salary

ganotherapy
06. 03. 2008
0 views

ganotherapy

06 Steve Blanchet
09. 10. 2007
0 views

06 Steve Blanchet

IEW2005 Maeda
11. 04. 2008
0 views

IEW2005 Maeda

2005 Annual Meeting
13. 04. 2008
0 views

2005 Annual Meeting

supercell morphology2
07. 10. 2007
0 views

supercell morphology2

DA Portals
13. 03. 2008
0 views

DA Portals

Sainsel2 kickoff
24. 10. 2007
0 views

Sainsel2 kickoff

cannone
26. 02. 2008
0 views

cannone

5 Toscanini Ben Avi
06. 12. 2007
0 views

5 Toscanini Ben Avi

Oakland Tech Summit 2
29. 10. 2007
0 views

Oakland Tech Summit 2

03 OceanCirculation
07. 04. 2008
0 views

03 OceanCirculation

TSJMediaRlns
08. 10. 2007
0 views

TSJMediaRlns

14 WebSuche Ranking IV
19. 10. 2007
0 views

14 WebSuche Ranking IV

tacit
19. 02. 2008
0 views

tacit

enssup2004HR
02. 11. 2007
0 views

enssup2004HR

John Fenn
15. 10. 2007
0 views

John Fenn

Torch Presentation 5 01
03. 10. 2007
0 views

Torch Presentation 5 01

6 24 Switzerland
17. 10. 2007
0 views

6 24 Switzerland

JVA WorldeId
20. 03. 2008
0 views

JVA WorldeId

216f06 India Travel Guide
25. 03. 2008
0 views

216f06 India Travel Guide

am studies4
16. 03. 2008
0 views

am studies4

NASAtechnology
15. 11. 2007
0 views

NASAtechnology

Presentation 20April
10. 04. 2008
0 views

Presentation 20April

italy MLB
07. 11. 2007
0 views

italy MLB

Claude Research ALADIN DA
24. 10. 2007
0 views

Claude Research ALADIN DA

OME standards 28mar07
12. 10. 2007
0 views

OME standards 28mar07

Rasmus Christiansen Copenhagen
18. 03. 2008
0 views

Rasmus Christiansen Copenhagen

hinkson
27. 02. 2008
0 views

hinkson

GA27 mm
17. 10. 2007
0 views

GA27 mm

Gromov2006Rome
12. 10. 2007
0 views

Gromov2006Rome

11en
24. 03. 2008
0 views

11en